"Velindre Cancer Centre is part of Velindre University University NHS Trust and provides specialist cancer services to 1.5 million people living in South East Wales. Velindre is one of the largest cancer centres in the UK. The Cancer Centre is a specialist treatment, teaching and research and development centre for non-surgical oncology, treating patients with chemotherapy, radiotherapy and related treatments, and caring for patients with specialist palliative care needs."

During the past decade, Velindre Cancer Centre conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 32 clinical trials were completed, i.e. on average, 36% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 18 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velindre Cancer Centre" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "University College, London" with 15 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials sponsored, "Institute of Cancer Research, United Kingdom" with 13 trials sponsored and "Medical Research Council" with 13 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velindre Cancer Centre" #1 collaborator was "Cancer Research UK" with 21 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Cancer Trials Ireland" with 3 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 114 trials.

According to Clinical.Site data, the most researched conditions in "Velindre Cancer Centre" are "Breast Cancer" (27 trials), "Prostate Cancer" (18 trials), "Colorectal Cancer" (14 trials), "Ovarian Cancer" (9 trials) and "Metastatic Cancer" (7 trials). Many other conditions were trialed in "Velindre Cancer Centre" in a lesser frequency.

Most popular intervention types in "Velindre Cancer Centre" are "Drug" (164 trials), "Radiation" (36 trials), "Procedure" (32 trials), "Other" (27 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "adjuvant therapy" (15 trials), "Paclitaxel" (14 trials), "radiation therapy" (14 trials) and "Carboplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "Velindre Cancer Centre" are 136 trials for "All" genders, 34 trials for "Female" genders and 31 trials for "Male" genders.

Currently, there are NaN active trials in "Velindre Cancer Centre". 1 are not yet recruiting, 30 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in Velindre Cancer Centre, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Velindre Cancer Centre, 20 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".